The U.S. Food and Drug Administration (FDA) approved a home HIV test for the first time ever earlier this week.

The HIV test, called OraQuick, was created by a medical company called OraSure. The test can be taken at home, providing results in approximately 30 minutes. The idea behind OraQuick is to make testing accessible to those who do not have the means to see a doctor.

"Knowing your status is an important factor in the effort to prevent the spread of HIV," said Dr. Karen Midthun, director of the FDA's Center for Biologics Evaluation and Research. "The availability of a home-use HIV test kit provides another option for individuals to get tested so that they can seek medical care, if appropriate."

While the new home test is a great start to providing results to those who may not be able to receiving testing otherwise, OraQuick shouldn't be the final word on the matter. According to OraQuick trials, the home test was unable to detect a positive in 1 in every 12 patients that were infected. In addition, the test provided a false positive in 1 in every 5,000 cases.

Despite these drawbacks, the FDA approved the home test kit because it felt the advantages outweighed the disadvantages. According to the federal Centers for Disease Control and Prevention, about 1.2 million people in the U.S. have HIV and approximately 1 in 5 are unaware of it. With a new home test kit, those who are infected can seek early medical attention for treatment and also reduce the transmission rate.

Testing for HIV has certainly come a long way since the 1980s, when testing first began. In 2002, the FDA approved on-the-spot tests for clinics, and in 2005, the FDA started looking into the possibility of a home test for HIV.

The price for an OraQuick test is unknown, but reports estimate that it will cost more than $18. A call center is coupled with the test for those who need support when finding they have an HIV positive test.